1. Home
  2. FORR vs COEP Comparison

FORR vs COEP Comparison

Compare FORR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forrester Research Inc.

FORR

Forrester Research Inc.

HOLD

Current Price

$6.86

Market Cap

105.1M

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$16.40

Market Cap

91.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORR
COEP
Founded
1983
2017
Country
United States
United States
Employees
N/A
6
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.1M
91.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FORR
COEP
Price
$6.86
$16.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
62.5K
92.3K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.88
$6.80
52 Week High
$11.57
$21.41

Technical Indicators

Market Signals
Indicator
FORR
COEP
Relative Strength Index (RSI) 54.47 72.18
Support Level $6.60 $13.77
Resistance Level $6.99 $19.19
Average True Range (ATR) 0.37 1.15
MACD 0.00 0.47
Stochastic Oscillator 60.71 87.62

Price Performance

Historical Comparison
FORR
COEP

About FORR Forrester Research Inc.

Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Share on Social Networks: